Close Menu

In work appearing this week in PLoS Biology, scientists led by the University of Toronto's Charles Boone used a blend of phage display, yeast two-hybrid, and peptide array screening to scan billions of peptides in order to find SH3 domain binding partners in S. cerevisiae. After creating a "high-confidence yeast SH3 domain interaction map," they showed that the binding peptides were enriched for proteins involved in endocytosis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.